Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 14,400
Avg Vol 99,476
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 90%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well...

Industry: Medical Devices
Sector: Healthcare
Phone: 416 699 5273
Fax: 416 699 5250
Address:
41 Hollinger Road, Toronto, Canada
Buy_SoFi
Buy_SoFi Apr. 24 at 7:52 PM
$1.00+ by EoY Ferring already partnered with $TLTFF and I can only assume the new cohort of test patients are in the process of being treated for NMIBC. More partners will probably knock on the door; MIBC, GBM/Brain, Lung, pancreatic and HSV topical treatment. This has a multi-dollar buyout written all over... $IBRX $GSK $CGON $JNJ
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 24 at 7:06 PM
$TLTFF Keeps moving up..... Still dirt cheap
1 · Reply
Buy_SoFi
Buy_SoFi Apr. 24 at 6:20 AM
$CGON $IBRX Nah... $TLTFF Has a much better and more promising pipeline than $CGON. I STRONGLY suggest doing DD on theralase, once in a lifetime opportunity at rock bottom price. Generational wealth making opportunity.
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 23 at 6:01 PM
$TLTFF <---- Multi-multi bagger in the making. Mark this post. $CGON $MRK $IBRX $GSK
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 23 at 4:14 PM
$TLTFF Keeps moving up... Still cheap! Don't miss out... - HSV Topical (better than anything on market) - NMIBC - MIBC - Brain/GBM - Lung - Ruvidar + Rutherin - Ferring Partnership $MRK $CGON $IBRX $GSK
0 · Reply
Yosharoo
Yosharoo Apr. 23 at 3:15 AM
$TLTFF ALL THIS GREAT NEWS AND STOCK HASNT MOVED,WHATS HOLDING THIS DOWN?
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 21 at 5:43 PM
$TLTFF tic toc ... tic toc...
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 21 at 2:36 PM
$TLTFF 100% CR and survival for X-Ray activated Rutherin for MIBC. WOW! Topical Ruvidar showing better results for HSV than anything available on the market. $MRK $IBRX $CGON $GSK
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 20 at 7:58 PM
$TLTFF <--- load up while it's still dirt cheap. Big things are coming for Theralase and Ruvidar-Rutherin
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 13 at 10:19 PM
$TLTFF $MRK $IBRX $CGON $GSK 💯 All great companies but it's time to pay attention to $TLTFF Anktiva and Ruvidar & Rutherin are the future of cancer treatment (and potentially cancer prevention). Cure for HSV wouldn't be bad either.
0 · Reply
Latest News on TLTFF
No data available.
Buy_SoFi
Buy_SoFi Apr. 24 at 7:52 PM
$1.00+ by EoY Ferring already partnered with $TLTFF and I can only assume the new cohort of test patients are in the process of being treated for NMIBC. More partners will probably knock on the door; MIBC, GBM/Brain, Lung, pancreatic and HSV topical treatment. This has a multi-dollar buyout written all over... $IBRX $GSK $CGON $JNJ
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 24 at 7:06 PM
$TLTFF Keeps moving up..... Still dirt cheap
1 · Reply
Buy_SoFi
Buy_SoFi Apr. 24 at 6:20 AM
$CGON $IBRX Nah... $TLTFF Has a much better and more promising pipeline than $CGON. I STRONGLY suggest doing DD on theralase, once in a lifetime opportunity at rock bottom price. Generational wealth making opportunity.
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 23 at 6:01 PM
$TLTFF <---- Multi-multi bagger in the making. Mark this post. $CGON $MRK $IBRX $GSK
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 23 at 4:14 PM
$TLTFF Keeps moving up... Still cheap! Don't miss out... - HSV Topical (better than anything on market) - NMIBC - MIBC - Brain/GBM - Lung - Ruvidar + Rutherin - Ferring Partnership $MRK $CGON $IBRX $GSK
0 · Reply
Yosharoo
Yosharoo Apr. 23 at 3:15 AM
$TLTFF ALL THIS GREAT NEWS AND STOCK HASNT MOVED,WHATS HOLDING THIS DOWN?
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 21 at 5:43 PM
$TLTFF tic toc ... tic toc...
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 21 at 2:36 PM
$TLTFF 100% CR and survival for X-Ray activated Rutherin for MIBC. WOW! Topical Ruvidar showing better results for HSV than anything available on the market. $MRK $IBRX $CGON $GSK
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 20 at 7:58 PM
$TLTFF <--- load up while it's still dirt cheap. Big things are coming for Theralase and Ruvidar-Rutherin
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 13 at 10:19 PM
$TLTFF $MRK $IBRX $CGON $GSK 💯 All great companies but it's time to pay attention to $TLTFF Anktiva and Ruvidar & Rutherin are the future of cancer treatment (and potentially cancer prevention). Cure for HSV wouldn't be bad either.
0 · Reply
PhantomZ
PhantomZ Apr. 13 at 12:09 PM
$TLTFF $MRK $IBRX $CGON $GSK no other animal model for MIBC comes even close. 100% CR and survival for X-Ray activated Rutherin for MIBC. https://stockhouse.com/news/press-releases/2026/04/13/theralase-r-reports-complete-response-with-x-ray-activated-rutherrin-r-in-muscle
0 · Reply
newsfile_corp
newsfile_corp Apr. 13 at 11:01 AM
https://nfne.ws/292023 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
newsfile_corp
newsfile_corp Apr. 10 at 11:01 AM
https://nfne.ws/291828 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
RobertX916
RobertX916 Mar. 20 at 5:43 PM
$TLTFF Adding for a long term hold. I like what I have been reading for this and the bio sector…. Gotta buy something even during a shooting war…
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 19 at 4:13 PM
$IBRX Keep an eye on $TLTFF (Theralase) while we wait for more Anktiva news. They have VERY competitive numbers for NMIBC and working on HSV treatment better than anything on the market. Worth putting on your watchlist.
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 17 at 1:57 PM
$TLTFF <---- Keep an eye on this one $GILD $IBRX $MRK $TEVA HSV treatment far superior to current Acyclovir. NMIBC cure very competitive with Anktiva (Ruvidar)
1 · Reply
Buy_SoFi
Buy_SoFi Mar. 17 at 12:54 AM
0 · Reply
newsfile_corp
newsfile_corp Mar. 10 at 11:01 AM
https://nfne.ws/287848 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
prismmarketview
prismmarketview Mar. 9 at 6:42 PM
Theralase $TLTFF Reports Promising Results for X-Ray-Activated Rutherrin in Bladder Cancer Research https://prismmarketview.com/theralase-reports-promising-results-for-x-ray-activated-rutherrin-in-bladder-cancer-research/
0 · Reply
newsfile_corp
newsfile_corp Mar. 9 at 11:01 AM
https://nfne.ws/286595 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 2 at 10:47 PM
$IBRX You will want to include Ruvidar by $TLTFF to that list. Just about to get approved. Ruvidar Monotherapy CR of +64% (after a SINGLE treatment) and starting a new cohort with combined treatment with Adlistarin. I'm building my position in both.
1 · Reply
Buy_SoFi
Buy_SoFi Feb. 26 at 7:44 PM
$IBRX $TLTFF is pretty damn close. Super early too. (I hold both)
1 · Reply